ARCHIVES

Angiogenesis Inhibitor In Phase III Trials For Metastatic Colorectal Cancer

This article is from The Cancer Letter archive.

Vol. 26 No. 9 | September 26, 2003

Download PDF Visit The Full Archive

Related Articles

Over $20 Million Carved Out From Statistical, Operations Centers

May 16, 2014

CPT-11, Gemcitabine Increase Survival Of Pancreatic Cancer

March 29, 2002

Deflecting Earmarks, NCI Advisors Lay Out Research Opportunities In Breast, Prostate

February 26, 1999

Immune System Booster Shown Safe For Prostate Cancer; Fewer Side Effects

August 29, 2008

NCI Intends To Extend OSCC Two More Years

October 3, 1986

Task Force Members Give Mea Culpa at Congressional Hearing

December 4, 2009